Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 12:01 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 985–1008 of 1,821 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: Renal Failure, Acute Renal Failure, Chronic Renal Failure, Chronic Kidney Diseases, End Stage Renal Disease
Interventions: ELISIO™-HX Dialyzer; Device
Lead sponsor: Nipro Medical Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Depression, Anxiety, Satisfaction, Well-being
Interventions: Comprehensive Well-Being Intervention; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 293 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Substance Use
Interventions: Ecological Momentary Assessment (EMA; Metricwire) Prompts 3x/day, Ecological Momentary Assessment (EMA; Metricwire) Prompts 6x/day, Incentive Structure - fixed, Incentive Structure - prize based; Behavioral
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 18 Years to 24 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Norovirus Infections
Interventions: Open label Bivalent GII.4/GI.1 high dose vaccine 2×10 to the power 11 IU/dose, Bivalent GII.4/GI.1 high dose vaccine 2×10 to the power 11 IU/dose, Bivalent GII.4/GI.1 medium dose vaccine 1×10 to the power 11 IU/dose, Placebo; Drug
Lead sponsor: Vaxart; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 135 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 3
States / cities: Long Beach, California • Lenexa, Kansas • Saint Paul, Minnesota

Conditions: Diet, Healthy, Blood Sugar; High, Diabetes, Appetite and General Nutritional Disorders, Appetitive Behavior
Interventions: WR, LB, MB, HB, WR+50g HFCS, LB + 50 g HFCS, MB + 50 g HFCS, HB + 50 g HFCS; Other
Lead sponsor: Washington State University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Asthma, Allergic Asthma, Non-allergic Asthma
Interventions: Nutritional approach for asthma, Low Caloric Shake, whole lung allergen challenge; Dietary Supplement · Biological
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Smoking, Smoking Cessation, Smoking Reduction, Smoking Behaviors
Interventions: Reduction (relocation and reduction of personal smoking) and cessation, Resident Endorsement; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 405 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Otitis Media
Interventions: Nontypeable Haemophilus influenzae; Biological
Lead sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD); NIH
Eligibility: Not listed
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1997 – 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Malnutrition
Interventions: Not listed
Lead sponsor: ThedaCare; Other
Eligibility: 18 Years to 110 Years
Enrollment: 607 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Appleton, Wisconsin • Neenah, Wisconsin

Conditions: Psychology, Social, Adolescent Behavior
Interventions: Gun handling behavior, Debriefing; Behavioral · Other
Lead sponsor: Ohio State University; Other
Eligibility: 8 Years to 12 Years
Enrollment: 245 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Muscle Protein Synthetic Response to Protein, Muscle Protein Synthesis, Muscle Health, Protein Metabolism, Recreational Activities, Isotope Labeling
Interventions: Resistance Exercise, Potato and Beef, Bread and Beef, Beef; Behavioral · Dietary Supplement
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 19 Years to 40 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Myopia
Interventions: LASIK; Procedure
Lead sponsor: Stanford University; Other
Eligibility: Not listed
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Stanford, California

Conditions: Human Papilloma Virus
Interventions: HPV Educational Intervention; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Influenza, COVID-19, Communication Research, Health Behavior, Respiratory Viral Infection
Interventions: Science Communication Curriculum Cohort 1, Science communication curriculum Cohort 2, Science communication curriculum Cohort 3, Science communication curriculum Cohort 4; Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 99 Years
Enrollment: 1,400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 4
States / cities: Chicago, Illinois • Iowa City, Iowa • Ann Arbor, Michigan

Conditions: HPV, HPV Associated Cancers, HPV Cancers, Cervical Cancer Screening, Cervical Cancer (Early Detection)
Interventions: Cervical Cancer Screening; Diagnostic Test
Lead sponsor: University of Rochester; Other
Eligibility: 30 Years to 65 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Body Image
Interventions: psychological; Other
Lead sponsor: Chapman University; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Orange, California

Conditions: HIV, Mental Health, Substance Use, STI
Interventions: Automated Messaging & Monitoring, Peer Support, Coaching; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 12 Years to 24 Years
Enrollment: 1,478 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 2
States / cities: Los Angeles, California • New Orleans, Louisiana

Conditions: Alport Syndrome
Interventions: Vonafexor; Drug
Lead sponsor: Enyo Pharma; Industry
Eligibility: 16 Years to 55 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 7
States / cities: Birmingham, Alabama • Los Angeles, California • Boise, Idaho + 4 more

Conditions: Adolescent Immunizations Among Clinic Population
Interventions: Not listed
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 11 Years to 21 Years
Enrollment: 223 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Pancreatitis, Chronic
Interventions: Per-oral Pancreatoscopy-guided Lithotripsy, Extracorporeal Shock-Wave Lithotripsy; Procedure
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 89 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: PSC
Interventions: Radiotracer Injection, Contrast Media, Magnetic Resonance, Imaging; Drug · Diagnostic Test
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 99 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Vaccination, Wastewater Surveillance
Interventions: Wastewater vaccine prompts; Behavioral
Lead sponsor: Syracuse University; Other
Eligibility: Not listed
Enrollment: 100,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Cannabis, Psychotic Disorders
Interventions: THC, Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 21 Years to 35 Years
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Gestational Diabetes
Interventions: Education; Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 199 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Premarket Clinical Safety Assessment of the ELISIO™-HX

A Tailored and Digital Approach to Address Equity and Support Well-being for Healthcare Workers in the Era of COVID

EMA of Substance Use in Homeless Youth

A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers

Barley Beta-glucan, Glycemic Control, and Appetite

Asthma Inflammation Research

Supporting Smoke-Free Policy Compliance in Public Housing

Vaccination for Middle Ear Infection

Comparison of Nutrition Risk Screens

Follow-up Gun Study: Can Safety Videos Mitigate Interest in Guns in Children?

Diet Synergy in Muscle Protein Synthesis

Effect of Preoperative Pupil Size on Quality of Vision After Wavefront-Guided LASIK

Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine

Dime La VerDAD: Verify, Debunk, and Disseminate

Emergency Department-based Cervical Cancer Screening Through Self-sampling

Body Positive Images and Photo Modification Cues on Social Media

Engaging Seronegative Youth to Optimize HIV Prevention Continuum

Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1)

Facilitating Completion of HPV Vaccination

ESWL vs. Pancreatoscopy-guided Lithotripsy for Painful Chronic Calcific Pancreatitis

PET/MRI of Primary Sclerosing Cholangitis

Wastewater Surveillance to Boost COVID-19 Vaccine Uptake

Cannabinoids and Cerebellar-Motor Functioning

Gestation Diabetes N'Teractive Media-based Education (GDnME)